The fertility industry is a vital and rapidly-expanding sector in global healthcare, fueled by demographic shifts, tech innovations, evolving social norms, and tighter regulations. Once a niche service primarily for couples with infertility, assisted reproductive technologies (ART) now drive family planning, gender-inclusive care, and solutions to demographic challenges
GlobalCorporate/Commercial Law
The fertility industry is a vital and rapidly-expanding sector
in global healthcare, fueled by demographic shifts, tech
innovations, evolving social norms, and tighter regulations. Once a
niche service primarily for couples with infertility, assisted
reproductive technologies (ART) now drive family planning,
gender-inclusive care, and solutions to demographic challenges.
With approximately 1 in 6 of adults affected by infertility, the
demand for advanced, accessible services is surging1.
The global fertility market, projected to hit $87.1 billion by
2034, is set to grow at a 9.1% CAGR from 2025 to
20342.
Our latest insights paper explores these themes, alongside
recent M&A transactions shaping the industry and reveals a
broader outlook for the sector.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
View source